Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature.

BackgroundChildhood obesity is associated with elevated blood concentrations of inflammation markers. It is not known to what extent inflammation precedes the development of obesity.MethodsIn a cohort of 882 infants born before 28 weeks of gestation, we examined relationships between concentrations of 25 inflammation-related proteins in blood obtained during the first two postnatal weeks and body mass index at 2 years of age.ResultsAmong children delivered for spontaneous indications (n=734), obesity was associated with elevated concentrations of four proteins (IL-1β, IL-6, TNF-R1, and MCP-1) on the first postnatal day; one protein (IL-6) on postnatal day 7; and two proteins (ICAM-3 and VEGF-R1) on postnatal day 14. Among children delivered for maternal or fetal indications (n=148), obesity was associated with elevated concentrations of seven proteins on the 14th postnatal day. In multivariable models in the spontaneous indications subsample, elevated IL-6 on day 1 predicted obesity (odds ratio: 2.9; 95% confidence limits: 1.2, 6.8), whereas elevated VCAM-1 on day 14 predicted overweight at 2 years of age (odds ratio: 2.3; 95% confidence limits: 1.2, 4.3).ConclusionsIn this cohort, neonatal systemic inflammation preceded the onset of obesity, suggesting that inflammation might contribute to the development of obesity.

Introduction

Using current expert panel definitions, which define obesity in children as a BMI at or above the 95th percentile for age and sex, and overweight as between the 85th and 95th percentiles, approximately 33% of US children and adolescents are overweight or obese.(1) Childhood obesity is associated with increased risk of numerous health problems, particularly cardio-metabolic disorders.(2) Because of the morbidity and mortality related to obesity, identifying possible precursors is of utmost importance.

Several prenatal and early-infancy factors predict obesity in later childhood. Maternal pre-pregnancy obesity,(3) high maternal gestational weight gain,(4 ) and maternal gestational diabetes(5) are all antenatal risk factors for later obesity. Preterm birth is a perinatal risk factor,(6) as is greater weight gain within the first postnatal week.(7)

Obesity in adults is characterized by a state of chronic low-grade inflammation.(8) Children with obesity(9) and children with elevated measures of adiposity (10) are more likely than others to have high circulating levels of several markers of inflammation, including both pro-inflammatory cytokines and acute-phase proteins. Most investigators explain this relationship by hypothesizing that obesity promotes inflammation. An alternative (and/or additional) explanation is that some inflammation precedes the obesity.(11) Prenatal and perinatal exposures might increase inflammatory mediators that play a role in metabolic programming (appetite control or hormonal environment) through epigenetic regulation of gene expression).(12)

Scant research addresses temporality between inflammation and obesity in childhood, and no studies examine the relationship between elevated perinatal concentrations of circulating inflammatory proteins and subsequent obesity. Therefore, we sought to evaluate to what extent neonatal inflammation is an antecedent of early childhood obesity in a preterm population. In a cohort of infants born prior to 28 weeks gestation (extremely low gestational age newborns; ELGANs), we investigated the relationship between circulating inflammation-related proteins measured during the first few postnatal weeks and obesity at age 2 years, when BMI standards are well-defined. We studied children who were born extremely preterm because children born prematurely and those born small for gestational age (SGA) are at increased risk of obesity in childhood compared to children born at term, independent of other demographic, physiological, environmental, and cultural factors also related to obesity.(6,13)

Methods

Study Participants

The ELGAN study was originally designed to identify characteristics and exposures that increase the risk of structural and functional neurologic disorders in ELGANs.(14) During the years 2002-2004, the 1249 mothers of 1506 infants delivered before 28 weeks gestation at one of 14 participating institutions in the United States consented for their children's participation in the study. Data collection tools and procedures were uniform across the 14 sites. The enrollment and consent processes were approved by the individual institutional review boards. Twelve hundred participants survived to two years of age (age adjusted for degree of prematurity) and 1056 of these children came for neurodevelopmental and health assessments at that age. From the subset of study participants who came for evaluation at two years, we had measurements of inflammation-related blood proteins measured in blood spots obtained during the first two postnatal weeks and measurement of height and weight at two years for 882 children (73.5% of all survivors and 83.5% of survivors who were evaluated at two years).

Demographic and pregnancy variables

After delivery, a trained research nurse interviewed each mother in her native language using a structured data collection and following procedures contained in a manual. The mother's report of her own characteristics and exposures, as well as the sequence of events leading to preterm delivery was taken as truth, even when her medical record provided discrepant information. The maternal report disagreed with the clinical record in less than 5% of comparisons, and in our experience has been more internally consistent than what physicians recorded in medical records.(15)

Shortly after discharge, the research nurse reviewed the maternal chart using a second structured data collection form to collect information about events after admission. The spontaneous initiators of preterm delivery (i.e., preterm labor, prelabor rupture of the fetal membranes, placental abruption, cervical insufficiency), maternal indicators (including preeclampsia), and delivery for fetal indications are defined elsewhere.(15)

Pre-pregnancy Maternal body mass index (BMI)

Each mother was asked to provide her height and her pre-pregnancy weight, which were used to calculate her BMI. The United States government classifies adult BMIs as follows: < 18.5 is underweight, 18.5–24.9 is healthy weight, 25.0–29.9 is overweight, 30.0–34.9 is obese, 35.0–39.9 is very obese, and ≥ 40 is extreme obesity.(16) We collapsed the five groups down to three: < 18.5, 18.5-29.9, and ≥ 30.

Placentas

A placenta was examined histologically for all but 72 of the infants. In keeping with the guidelines of the 1991 College of American Pathologists Conference, representative sections were taken from all abnormal areas as well as routine sections of the umbilical cord and a membrane roll, and full thickness sections from the center and a paracentral zone of the placental disc. After training to minimize observer variability, study pathologists examined the slides for histologic characteristics listed on a standardized data form they helped create.(17) Histologic chorioamnionitis was classified as grade 3 if the membranes and/or decidua had numerous large or confluent foci of neutrophils and as grade 4 if necrosis was present.

Infant Characteristics

Gestational age estimates were based on a hierarchy of the quality of available information with estimates based on the dates of embryo retrieval or intrauterine insemination or fetal ultrasound before the 14th week of gestation (62%) as the most desirable. Next most desirable in sequential order were estimates based on a fetal ultrasound at 14 or more weeks of gestation (29%), last menstrual period (7%), and recorded in the log of the NICU.

The birth weight Z-score represents the number of standard deviations the infant's birth weight was above or below the mean weight of infants at the same gestational age in referent samples not delivered for maternal or fetal indications.(18)

The overall change in weight over the interval between day 7 and day 28 was expressed as the difference between the weight on day 7 and the weight on day 28, divided by the weight on day 7, in kilograms. The growth velocity per day was then calculated by dividing the overall weigh change per kilogram of body weight by 21, the number of days in the interval between day 7 and day 28.

Documented early bacteremia was defined as recovery of an organism from blood drawn during first week, and late bacteremia as recovery of an organism from blood drawn during weeks 2, 3 or 4. Specific organisms were not identified.

The child's necrotizing enterocolitis status was classified according to the modified Bell staging system.(19) Chronic lung disease/bronchopulmonary dysplasia was defined as oxygen therapy at 36 weeks adjusted gestation.

BMI at Two Years

Height and weight, measured during the examination component of ELGAN, were used to calculate BMI (weight in kilograms divided by height in meters squared). Each child's BMI percentile for sex and age was determined by comparison to the CDC growth chart percentiles. Children with weight ≥95th percentile are considered obese; those with weight ≥85th to <95th percentile are considered overweight; and those with weight to ≥5th to <85th percentile are of healthy weight. (20)

Blood spot collection

Drops of blood from the newborns were collected on filter paper on postnatal days 1 (range: 1-3 days) (N = 861), 7 (range: 5-8 days) (N = 867), and 14 (range: 12-15 days) (N = 786). All blood was from what remained after specimens were obtained for clinical indications. Dried blood spots were stored at -70°C in sealed bags with desiccant until processed.

Protein measurements (Supplemental Table S1)

Additional details about the elution of proteins from the blood spots and measurement of proteins have been previously reported.(21) Proteins were measured in duplicate in the Laboratory of Genital Tract Biology of the Department of Obstetrics, Gynecology and Reproductive Biology at Brigham and Women's Hospital, Boston using the Meso Scale Discovery (MSD) multiplex platform and Sector Imager 2400 (MSD, Gaithersburg, MD). This electrochemiluminescence system has been validated by comparisons with traditional ELISA and produces measurements that have high content validity. (21)

The multiplex assays measuring up to 10 proteins simultaneously were optimized to allow detection of each biomarker within the linearity range of the eluted samples. The MSD Discovery Workbench Software was used to convert relative luminescent units into protein concentrations using interpolation from several log calibrator curves. Split quality control blood pools tested on each plate showed inter-assay variation of < 20% in the linearity range customized for the blood spot elution samples. The total protein concentration in each eluted sample was determined by BCA assay (Thermo Scientific, Rockford, IL) using a multi-label Victor 2 counter (Perkin Elmer, Boston, MA) and the measurements of each inflammation protein normalized to mg total protein.

We measured the following 25 proteins: C-Reactive Protein (CRP), Serum Amyloid A (SAA), Myeloperoxidase (MPO), Interleukin-1 beta IL -1 beta, Interleukin-6 (IL-6), Interleukin-6 Receptor (IL-6R), Tumor Necrosis Factor-alpha (TNF-alpha, Tumor Necrosis Factor-alpha Receptor-1 (TNF-R1), Tumor Necrosis Factor-alpha Receptor-2 (TNF-R2), Interleukin-8 (IL-8; CXCL8), Monocyte Chemotactic Protein-1 (MCP-1; CCL2), Monocyte Chemoattractant Protein -4 (MCP-4; CCL13), Macrophage Inflammatory Protein-1 beta (MIP-1 beta; CCL4), Regulated upon Activation, Normal T-cell Expressed, and [presumably] Secreted (RANTES; CCL5), Interferon-inducible T cell Alpha-Chemoattractant (I-TAC; CXCL11), Intercellular Adhesion Molecule -1 (ICAM-1; CD54), Intercellular Adhesion Molecule -3 (ICAM-3; CD50), Vascular Cell Adhesion Molecule-1 VCAM-1; CD106), E-selectin (CD62E), Matrix Metalloproteinase-1 (MMP-1), Matrix Metalloproteinase-9 (MMP-9), Vascular Endothelial Growth Factor (VEGF), Vascular Endothelial Growth Factor Receptor-1(VEGF-R1; Flt-1), Vascular Endothelial Growth Factor Receptor-2 (VEGF-R2; KDR), Insulin Growth Factor Binding Protein-1 (IGFBP-1).

Data analysis

We evaluated the null hypothesis that ELGANS who have concentrations of inflammation-related proteins in the top quartile during the first two postnatal weeks are no more likely than others to be overweight or obese at 24 months.

We evaluated children delivered for spontaneous indications separately from those delivered for fetal or maternal indications for two reasons. First, in this sample, concentrations of inflammation-associated proteins in postnatal blood differ between these two groups.(22) Second, in this sample, the prevalence of fetal growth restriction was much higher among infants delivered for maternal or fetal indications than among those delivered for spontaneous indications.(23)

We first explored to what extent perinatal variables are related to growth velocity and to 2-year BMI category in groups of infants delivered for spontaneous indications and for maternal and fetal indications. We then explored the distribution of inflammation-related protein concentrations in the top quartile among 2-year BMI categories during each of three time intervals during the first postnatal weeks, separately for children whose birth was prompted by spontaneous indications and maternal/fetal indications.

We used time-oriented multivariable regression, specifically multinominal logistic regression, to control confounding.(24) This time-oriented approach to model selection is appropriate because antenatal antecedents of BMI at 2 years can influence the likelihood of postnatal antecedents. We categorized sets of antecedents by the time they occur, or are identified (e.g., antenatal, day 1,7, and 14 protein measures, and later postnatal). We then used a step down procedure, seeking a parsimonious solution without interaction terms. The initial step in this multi-step analysis included only prenatal variables. We eliminated variables that were not significantly associated with overweight and obesity until the only variables that remained were those significantly associated with either overweight or obesity. We then re-entered each previously eliminated variable to see if it might add significant information to the most parsimonious model. Only those variables with statistically significant associations with BMI at 2 years were carried forward to the next step. The second, third, and fourth steps considered, day 1, day 7, and day 14 protein variables, respectively. At each step, non-significant variables were dropped and statistically significant variables retained from earlier steps could not be dropped. Dropped variables were reconsidered as described for step 1. Having “adjusted” for prenatal variables and proteins on days 1, 7, and 14, we added variables for the lowest and highest quartiles of growth velocity between days 7 and 28 to see if they added significant information about child overweight and obesity at 2 years. These models allowed us to calculate odds ratios and 95% confidence intervals. The multinomial outcome was BMI centile 85-94 (overweight) and ≥ 95 (obese) and BMI centile < 85 (healthy weight) was the referent category.

Results

Sample description (Table 1)

Children who were members of the cohort but were not evaluated at 2 years were more likely to have been born to mothers with pregnancy weight gain in the lowest quartile for our sample and were more likely to have had gestational diabetes. Of the 882 infants in the study sample, 734 were delivered for spontaneous indications, and 148 were delivered for maternal (N=114) or fetal indications (N=34). Among infants who survived to 28 days and were weighed on both occasions, the upper bound of the lowest quartile of growth velocity was 13.8, the median was 18.3, and the upper bound of the third quartile was 22.6.

Infants delivered for spontaneous indications (Table 2)

Infants with obesity at age 2 years were more likely than others to have a mother who identified as Black, and who was obese prior to her pregnancy. The proportion of children whose placenta was inflamed increased with increasing 2-year BMI. Children with obesity were less likely than others to be male, have a twin or triplet, or a birth weight at or below 750 grams, and more likely to have had an early growth velocity in the top quartile.

Infants delivered for maternal or fetal indications (Table 3)

Infants who had necrotizing enterocolitis or chronic lung disease were more likely than others to be obese at age 2 years. They were less likely than others to have a mother with obesity just before the pregnancy, to be male, or to have been born during the 23rd or 24th week of gestation.

Protein concentrations in the blood of infants delivered for spontaneous indications (Table 4)

Among children who are obese, the frequency of a top-quartile day-1 concentration of IL-1β, IL-6, TNF-R1, and MCP-1 was 1.5 to 1.9 times greater than the frequency among healthy weight children. Children who were obese had a frequency of top quartile day-7 concentration of IL-6 and top quartile concentrations of ICAM-3 and VEGF-R1 on day 14 that was at least 1.5 times that of healthy weight children. Children who are overweight had frequencies of a top-quartile day-1 concentration of VCAM-1, a top quartile day-7 concentration of IL-1β, and a top quartile day-14 concentration of IL-6R, ICAM-1 and VCAM -1 that was at least 1.5 times that of healthy weight children. Overweight children were 3 times less likely to have a top quartile day-14 concentration of MMP-1.

Protein concentrations of infants delivered for maternal or fetal indications (Table 5)

With only a maximum of 8 overweight children and 12 obese children, just one more or less child in either of these weight categories in the top quartile appreciably alters our perception of the proportion who have a concentration in the top quartile. Children who were obese at 2 years were less likely than others to have had elevated concentrations of inflammation-related proteins in the day-1 blood spot. This trend was less evident in the day-7 blood spot. Children who are obese were more likely than others to have had a day-14 top quartile concentration of CRP, MPO, IL-1β, IL-6, TNF-α, IL-8, MMP-9, and VEGF-R1. Overweight children were more likely than others to have a day-7 top quartile concentration of SAA, IL-1β, I-TAC and IGFBP-1, and a day-14 top quartile concentration of CRP, I-TAC. E-SEL, VEGF, and VEGF-R1

Multinomial, time-oriented risk models of the antecedents of being overweight or obese at age 2-years among infants delivered for spontaneous indications (Table 6)

We addressed the contribution of antecedents to overweight (BMI centiles 85-94) and obesity (BMI centiles ≥ 95) that occurred before measurement of the day-1 proteins, by beginning with a model that included characteristics evident at the time of delivery. In its most parsimonious form, the risk of obesity was significantly reduced among boys [odds ratio (OR)=0.4 (95% confidence interval (CI): 0.2, 0.99)], children born with a sibling [OR=0.2 (95% CI: 0.1, 0.7)], or those whose birth weight was ≤750 grams [OR=0.2 (95% CI: 0.1, 0.8)].

When the top quartile day-1 protein concentrations was added to multivariable analysis of factors associated with overweight and obesity, only IL-6 added significant discriminating information about increased risk of obesity [OR=2.9 (95% CI: 1.2, 6.8)]. No day-7 protein concentrations contributed to the model.

Adding top quartile day-14 protein concentrations did not add significant information about obesity, but a top-quartile VCAM-1 concentration was associated with increased risk of being overweight [OR=2.3 (95% CI: 1.2, 4.3)], while a top-quartile MMP-1 concentration was associated with reduced risk [OR=0.2 (95% CI: 0.1, 0.6)].

Because growth velocity was measured for the 2nd through 4th weeks, variables for highest and lowest quartiles of growth velocity were added after the day-14 protein measurements. Neither highest nor lowest growth velocity quartile added significant information about the risk of being overweight or obese two years later, although highest growth velocity quartile was nearly significantly associated with obesity at 2 years [OR=2.6 (95% CI: 1.00, 6.5)].

The relatively small sample of infants delivered for fetal or maternal indications did not allow for confidence in creating stable multivariable models. Consequently, no multivariable model of overweight or obesity at age 2 years is presented for the subsample of children delivered for fetal or maternal indications.

Discussion

We have two major findings. First, among ELGANs who were delivered for spontaneous indications, infants who were obese at age 2 years were more likely than others to have had elevated levels of inflammation proteins in blood obtained on the first postnatal day. Second, among those who were delivered for maternal or fetal indications, the perinatal inflammation associated with obesity at age 2 years was first evident in blood obtained on postnatal day 14. Even after controlling for multiple other factors in parsimonious multivariable models of obesity risk in the larger spontaneous indications subsample, an elevated concentration of day-1 IL-6 is a strong predictor of obesity at age 2, and an elevated concentration of day-14 VCAM-1 is a strong predictor of overweight. Thus, our findings support the hypothesis that inflammation can precede the onset of obesity, although obesity might well also exacerbate responses to inflammatory stimuli at later ages.

Why did the pattern for spontaneous indications differ from the pattern for maternal/fetal indications?

The systemic inflammation evident on postnatal day 1 in those delivered for spontaneous indications might reflect in utero phenomena resulting in fetal, and hence, very early neonatal inflammation(25) In contrast, the systemic inflammation in those delivered for maternal or fetal indications probably reflects a relative absence of in utero inflammatory stimuli, and a proclivity to respond intensely to ex utero inflammatory stimuli.(22,26,27) The pattern of inflammatory cytokines related to obesity on Day 14 among children who were delivered for maternal or fetal indications was similar to the Day-1 pattern for children delivered for spontaneous indications.

Why did only a few proteins have significant associations in the multivariable models?

In parsimonious multivariable models, only those risk factors are added (to the model) that provide unique supplemental risk information. We found that elevated concentrations of only one inflammation-associated protein conveyed information about obesity and only one conveyed risk information about overweight. This was expected in light of the highly inter-correlated relationships among inflammation-related proteins in this cohort. (28)

Epigenetic phenomena/fetal programming

Evidence of presumed fetal programming in the ELGAN Study comes from the observation that severely growth-restricted newborns did not have a systemic inflammatory signal on the first postnatal day, but two weeks later had a stronger inflammatory response than newborns who were not growth restricted.(22) Months later severely growth-restricted newborns were at increased risk of bronchopulmonary dysplasia.(26) Two years later, they were more likely than their peers to have a low score on a cognition assessment.(23)

Although our day-1 blood specimens are not umbilical cord specimens, the inflammation evident in these samples does reflect maternal and/or in utero influences.(25,29,30) Such early inflammation associated with inflammatory placenta and pregnancy characteristics is markedly diminished by day 7 and essentially no longer evident by day 14. Consequently, the blood sampled on days 7 and 14, which provide evidence of systemic inflammation, is unlikely to reflect information about pre-delivery inflammatory stimuli.

In light of these observations, we raise the possibility that some of the early associations with systemic inflammation in our extremely preterm sample might be evidence of fetal programming. If so, the inflammation we see associated with childhood obesity could be an early expression of the developmental programming that leads to adiposity in later childhood.(31)

The intestinal organisms now identified as “gut microbiota” influence the risk of obesity via multiple mechanisms, including energy balance, glucose metabolism, and low-grade inflammation.(32) These observations have led some to view obesity and inflammation as having a common etiology. Indeed, it is likely that a positive feedback loop exists between local inflammation in adipose tissue (e.g., the synthesis of adiponectin, leptin and resistin) and immune responses elsewhere in the body (e.g., the synthesis of pro-inflammatory cytokines and related proteins).(8)

Alternate Explanations

Behavioral explanations may also play a role in the later development of childhood obesity among these infants. Because intermittent and/or sustained inflammation shortly after birth is associated with a variety of disorders in ELGANs, it is possible that the inflammation we associate with later overweight and obesity is really an indicator of the increased risk of disorders that will prompt the parent to perceive her child as more vulnerable than other children. Because parents who perceive their children as vulnerable treat them differently than parents who do not perceive their children as so vulnerable,(33) feeding behaviors that distinguish children perceived as vulnerable might differ from those not perceived as so vulnerable.(34) Parents and other caregivers who perceive preterm newborns as vulnerable might respond by overfeeding in order to encourage catch-up growth, though this is not known.

Limitations

We are unable to distinguish between causation and association as explanations for what we found. In addition, the sickest infants were more likely to receive more significant treatment protocols than others who were not quite so sick, making our study prone to confounding by indication, which some feel can never be completely eliminated.(35) Compensatory parenting and over-feeding can be viewed as just another form of confounding by indication. With only 34 children delivered for spontaneous indications who developed obesity and 700 children who had not developed obesity at age 24 months corrected, our study has a power of 0.83 to detect a doubling of the risk of obesity associated with protein concentrations in the top quartile. Our short-duration measure of growth velocity is limited to the end of the first postnatal month when weights were last obtained routinely.

The interrelatedness of early and late systemic inflammation(36) limits our ability to tease apart the contributions of each to the occurrence of each dysfunction. We are also limited by the relatively small number of proteins measured. Inflammation is a broad and complex phenomenon,(37) and we have assessed a very small part of it. In addition, the proteins we measured might not be in the causal and/or repair chains, but merely surrogates for other proteins in their broad group.(38) We relied on blood specimens obtained for clinical indications. As their cardio-pulmonary function and blood gas exchange stabilized, infants were less likely than their sicker peers to have blood drawn on day 14. Consequently, selection bias probably occurred to some extent.

Among the strengths of our study are the selection of infants based on gestational age, not birth weight,(39) prospective collection of all data, modest attrition, and finally, protein data of high quality,(21) and high content validity.(25,29)

Conclusion

In conclusion, obesity at age 2 years among children who were born extremely preterm is predicted by perinatal systemic inflammation. This might be a manifestation of fetal programming in the development of obesity and may be critical to our understanding of obesity in all children. Future research should examine if our findings can be replicated among children born very preterm, as well as assessing if similar fetal programming is evident in children born at term. Preventing and managing obesity in children will require an improved understanding of the multitude of factors involved in the complex development of obesity.

Supplemental Table S1. List of proteins measured and abbreviations.

Table 1

The percent of children who are in or not in the analysis sample who also had the characteristic listed on the left. These are column percents.

Characteristics of the mother and infant		In the analysis sample?		Row N
		Yes	No
Public insurance	Yes	38	40	418
Black race	Yes	28	22	291
Hispanic	Yes	11	16	129
Pre-pregnancy BMI	< 18.5	8	7	82
	> 30	21	20	221
Pregnancy weight gain quartile	Highest	24	29	264
	Lowest	24	47	238
Gestational diabetes	Yes	49	67	37
Histologic chorioamnionitis*	Yes	33	35	369
	missing	9	6	93
Indication for delivery	PTL	45	46	498
	pPROM	22	21	240
	PE	13	14	144
	Abruption	11	8	118
	Cerv insuf	5	6	58
	FI	4	5	44
Cesarean delivery	Yes	66	69	736
Sex	Male	52	50	569
# of fetuses	2+	33	38	373
Gestational age (weeks)	23-24	21	16	220
	25-26	47	43	508
Birth weight (grams)	≤ 750	37	31	397
	750-1000	44	44	487
BW Z-score**	< -2	5	5	58
	≥ -2, < -1	13	15	145
% Weight gain, week 1	Highest Q	24	23	257
Growth velocity† quartile	Lowest	24	29	266
	Highest	24	18	249
Bacteria in blood	Week 1	6	7	69
	Week 2+	26	21	276
Necrotizing enterocolitis††	Yes	8	6	83
Chronic lung disease§	Yes	53	41	443
Maximum number of infants		882	220	1102

Grades 3 and 4

Yudkin standard

1000 × [(weight day 28 - weight day 7) / weight day 7] / 21

Stage IIIa, IIIb, or perforation

Receiving oxygen at 36 weeks postconceptional age

Table 2

The percent of children who were in the BMI category listed at the top of the column who also had the characteristic listed on the left. These are column percents. This table is restricted to infants whose delivery was for spontaneous indications (including preterm labor, preterm premature rupture of membranes, abruption or cervical insufficiency).

Characteristics of the mother and infant		Child's BMI centile at 24 months			Row N
		< 85	85-94	≥ 95
Public insurance	Yes	40	29	39	281
Black race	Yes	28	22	39	201
Hispanic	Yes	11	10	6	80
Pre-pregnancy	< 18.5	9	9	0	62
BMI	> 30	18	19	35	134
Pregnancy weight gain quartile	Highest	23	19	16	158
	Lowest	23	28	42	171
Gestational diabetes	Yes	6	2	6	39
Histologic chorioamnionitis*	Yes	39	43	47	289
	missing	10	7	9	72
Indication for delivery	PTL	55	45	50	396
	pPROM	27	27	21	193
	Abruption	13	20	18	101
	Cerv insuf	5	8	12	44
Cesarean delivery	Yes	62	50	56	443
Sex	Male	55	67	38	407
# of fetuses	2+	38	30	12	265
Gestational age (weeks)	23-24	24	23	18	174
	25-26	46	47	47	339
Birth weight (grams)	≤ 750	33	30	15	236
	750-1000	48	45	50	348
BW Z-score**	< -2	2	2	0	14
	≥ -2, < -1	8	3	6	58
% Weight gain, week 1	Highest Q	20	17	9	138
Growth velocity† quartile	Lowest	26	18	12	182
	Highest	22	32	35	171
Bacteria in blood	Week 1	6	7	0	44
	Week 2+	25	30	24	188
Necrotizing enterocolitis††	Yes	8	5	9	58
Chronic lung disease§	Yes	50	62	47	373
Maximum number of infants		640	60	34	734

Grades 3 and 4

Yudkin standard

1000 × [(weight day 28 - weight day 7) / weight day 7] / 21

Stage IIIa, IIIb, or perforation

Receiving oxygen at 36 weeks postconceptional age

Table 3

The percent of children who who were in the BMI category listed at the top of the column who also had the characteristic listed on the left. These are column percents. This table is restricted to infants who delivered for maternal or fetal indications.

Characteristics of the mother and infant		Child's BMI at 24 months			Row N
		< 85	85-94	≥ 95
Public insurance	Yes	35	38	42	52
Black race	Yes	28	38	33	42
Hispanic	Yes	9	25	0	13
Pre-pregnancy BMI	< 18.5	3	0	8	5
	> 30	33	50	8	46
Gestational diabetes	Yes	10	13	17	16
Histologic Chorioamnionitis*	Yes	3	0	0	4
	missing	5	0	8	8
Indication for delivery	Pre-eclampsia	77	88	75	114
	Fetal indications	23	13	25	35
Cesarean delivery	Yes	95	100	92	141
Sex	Male	34	63	25	52
# of fetuses	2+	15	25	33	25
Gestational age (weeks)	23-24	8	13	0	11
	25-26	47	63	75	74
Birth weight (grams)	≤ 750	60	88	67	92
	750-1000	30	13	25	42
BW Z-score*	< -2	23	25	25	34
	≥ -2, < -1	35	63	33	55
Growth velocity† quartile	Lowest	20	12	17	28
	Highest	27	38	42	43
Bacteria in blood	Week 1	7	0	0	9
	Week 2+	29	0	42	42
NEC†	Yes	6	13	25	12
CLD§	Yes	61	63	75	91
Maximum number of infants		128	8	12	148

Grades 3 and 4

Yudkin standard

1000 × [(weight day 28 - weight day 7) / weight day 7] / 21

Stage IIIa, IIIb, or perforation

Receiving O2 at 36 weeks PCA

Table 4

Percent of all children who had the BMI at the top of each column at age 24 months years who also had a concentration in the top quartile of the protein on the left on the postnatal days 1, 7, and 14. These are column percents. This table is restricted to infants who delivered for spontaneous indications (i.e., preterm labor, preterm premature rupture of membranes, abruption or cervical insufficiency).

	Protein	Day 1 (n=679)			Day 7 (n=688)			Day 14 (n=622)
		BMI centile at 24 months
		< 85	85-94	≥ 95	< 85	85-94	≥ 95	< 85	85-94	≥ 95
Systemic inflammation	CRP	26	28	10	23	18	10	23	23	17
	SAA	25	28	26	24	21	13	24	26	23
	MPO	29	25	19	28	21	32	25	21	20
Cytokines and receptors	IL-1β	26	33	45	24	37	29	23	19	20
	IL-6	27	25	52	24	23	39	24	17	17
	IL-6R	27	25	35	25	30	35	23	36	30
	TNF-α	26	35	32	26	28	29	24	19	30
	TNF-R1	28	30	42	26	23	29	24	30	17
	TNF-R2	26	33	35	26	18	23	24	32	17
Chemokines	IL-8	26	28	29	26	28	26	23	19	17
	MCP-1	24	30	42	23	25	29	23	23	20
	MCP-4	25	35	32	26	25	13	25	23	17
	MIP-1β	28	19	35	26	25	19	25	17	30
	RANTES	26	28	32	27	25	42	26	25	33
	I-TAC	26	21	35	24	14	29	25	21	30
Adhesion molecules	ICAM-1	26	28	29	22	18	19	22	36	20
	ICAM-3	29	28	23	29	30	32	24	28	37
	VCAM-1	26	40	23	27	26	29	25	42	27
	E-SEL	28	30	29	25	25	29	24	28	20
Matrix metallo-proteinases	MMP-1	28	23	23	27	14	39	27	9	33
	MMP-9	29	30	29	29	28	39	25	25	20
Angiogenic proteins	VEGF	28	28	19	29	25	39	26	15	33
	VEGF-R1	21	19	23	27	23	29	24	21	37
	VEGF-R2	26	28	29	25	19	29	23	30	23
	IGFBP-1	20	26	23	21	25	23	24	19	17
Maximum number of infants		591	57	31	600	57	31	539	53	30

Table 5

Percent of all children who had the BMI at the top of each column at age 2 years who also had a concentration in the top quartile of the protein on the left on the postnatal days 1, 7, and 14. These are column percents. This table is restricted to infants who delivered for maternal or fetal indications.

	Protein	Day 1 (n=134)			Day 7 (n=136)			Day 14 (n=128)
		BMI centile at24 months
		< 85	85-94	≥ 95	< 85	85-94	≥ 95	< 85	85-94	≥ 95
Systemic inflammation	CRP	20	0	8	47	14	33	39	50	44
	SAA	24	0	8	38	43	17	32	25	22
	MPO	10	13	8	14	14	17	27	13	56
Cytokines and receptors	IL-1β	15	13	8	22	43	33	35	38	67
	IL-6	15	0	0	62	29	33	35	25	56
	IL-6R	18	25	0	22	0	33	30	0	33
	TNF-α	16	13	0	26	29	29	36	25	67
	TNF-R1	13	0	0	29	14	17	31	38	33
	TNF-R2	15	13	0	33	14	17	32	13	22
Chemokines	IL-8	23	13	0	22	14	8	37	13	56
	MCP-1	28	13	25	32	14	25	37	25	33
	MCP-4	23	25	17	28	14	17	31	38	22
	MIP-1β	16	25	8	26	14	8	31	38	22
	RANTES	18	13	0	15	0	8	25	38	0
	I-TAC	19	25	8	28	43	17	22	50	22
Adhesion molecules	ICAM-1	20	0	0	46	0	33	43	0	33
	ICAM-3	10	13	8	10	14	0	29	25	33
	VCAM-1	19	13	0	17	0	33	20	13	33
	E-SEL	15	0	0	26	0	17	32	50	11
Matrix metallo-proteinases	MMP-1	17	0	8	20	0	33	19	25	11
	MMP-9	9	13	8	8	14	17	28	13	44
Angiogenic proteins	VEGF	9	13	0	8	14	8	22	63	22
	VEGF-R1	49	25	25	21	29	33	25	63	44
	VEGF-R2	20	0	0	32	0	8	41	13	11
	IGFBP-1	50	50	25	41	57	33	36	25	22
Maximum number of infants		114	8	12	117	7	12	111	8	9

Table 6

Odds ratios (95% confidence interval) of having a BMI category of overweight or obese with healthy weight as the referent group at age 2 years. These time-oriented models are limited to infants delivered for spontaneous indications (n=563). Bold numbers are significantly greater than 1.0. are significantly less than 1.0.

		BMI centile at 24 months
		85-94 (Overweight)	≥ 95 (Obese)
Pre-pregnancy BMI	≥ 30	1.1 (0.5, 2.2)	2.7 (1.1, 6.7)
Sex	Male	1.7 (0.9, 3.3)	0.4 (0.2, 0.99)
Multi-fetal pregnancy	Yes	0.8 (0.4, 1.5)	0.2 (0.1, 0.7)
Birth weight	≤ 750 g	0.8 (0.4, 1.6)	0.2 (0.1, 0.8)
Day 1 proteins	IL-6	0.8 (0.4, 1.6)	2.9 (1.2, 6.8)
Day 7 proteins	None
Day 14 proteins	VCAM-1	2.3 (1.2, 4.3)	1.6 (0.6, 4.0)
	MMP-1	0.2 (0.1, 0.6)	1.0 (0.4, 2.7)
Growth velocity	Lowest quartile	0.8 (0.4, 1.8)	0.3 (0.1, 1.6)
	Highest quartile	1.5 (0.8, 3.1)	2.6 (1.00, 6.5)